Category: Orthopedic Biomaterials
Baxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow
Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Baxter International Inc., a global leader in advancing surgical innovation, announced U.S. Food a... Read More
NuVasive Launches AttraX Scaffold Bone Graft
Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure San Diego, California-based NuVasive, Inc. has announced the U.S. launch of AttraX Scaffold, the c... Read More
Newly Founded Company, Datum Orthobiologics, to Apply Dental Technology in Orthopedics
Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Datum Biotech Ltd. has announced the founding of Datum Orthobiologics Ltd. Datum Orthobiologics wil... Read More
Medtronic Announces FDA Approval of Infuse(TM) Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants
Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Medtronic plc announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft i... Read More
Aziyo Biologics Expands Bone Repair Franchise with Launch of OsteGro
Register to receive a free Orthopedic Biomaterials Market Report Suite for US 2017-2023 synopsis and brochure Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced the l... Read More
Polymer Bone Graft Substitute Receives FDA Clearance
Register to receive a free Orthopedic Biomaterials Market Report Suite for US 2017-2023 synopsis and brochure Biotechnology startup Molecular Matrix Inc. has received 510(k) FDA clearance for a carb... Read More
Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment
Anika Therapeutics, Inc., a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, recently announced that its HA-base... Read More
Vivorté Announces the Commercial Availability of FORTERA and REGENTO Bone Grafting Solutions for Orthopedic Surgery
These newly introduced products join Trabexus EB, which first received 510(k) clearance in 2015. TRABEXUS EB is a self-setting, gradually resorbable, calcium phosphate matrix enhanced with partially ... Read More
The Taiwanese Bone Graft Substitute Market: A Small, But Profitable Target
Bone graft substitutes are widely used in a variety of indications, including dental, spine, trauma, large joint, foot & ankle, craniomaxillofacial, and oncology.... Read More- 3 of 4
- « Previous
- 1
- 2
- 3
- 4
- Next »
